ScholarIQanswers from OpenAlex
Crizotinib in <i>ROS1</i>-Rearranged Non–Small-Cell Lung Cancer
PaperCitations, authors & open-access status
Crizotinib in <i>ROS1</i>-Rearranged Non–Small-Cell Lung Cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Crizotinib in <i>ROS1</i>-Rearranged Non–Small-Cell Lung Cancer have?
ScholarIQcitation count
Crizotinib in <i>ROS1</i>-Rearranged Non–Small-Cell Lung Cancer has 2,002 citations in the OpenAlex counts ScholarIQ stores.
When was Crizotinib in <i>ROS1</i>-Rearranged Non–Small-Cell Lung Cancer published?
ScholarIQyear
Crizotinib in <i>ROS1</i>-Rearranged Non–Small-Cell Lung Cancer has 2014 year in the ScholarIQ index.
What is the open-access status of Crizotinib in <i>ROS1</i>-Rearranged Non–Small-Cell Lung Cancer?
ScholarIQoa status
Crizotinib in <i>ROS1</i>-Rearranged Non–Small-Cell Lung Cancer has closed oa status in the ScholarIQ index.
What is the DOI of Crizotinib in <i>ROS1</i>-Rearranged Non–Small-Cell Lung Cancer?
ScholarIQdoi
The DOI for Crizotinib in <i>ROS1</i>-Rearranged Non–Small-Cell Lung Cancer is on the source record.
What is the PMID of Crizotinib in <i>ROS1</i>-Rearranged Non–Small-Cell Lung Cancer?
ScholarIQpmid
The PMID for Crizotinib in <i>ROS1</i>-Rearranged Non–Small-Cell Lung Cancer is on the source record.
What is the OpenAlex record for Crizotinib in <i>ROS1</i>-Rearranged Non–Small-Cell Lung Cancer?
ScholarIQopenalex
The OpenAlex for Crizotinib in <i>ROS1</i>-Rearranged Non–Small-Cell Lung Cancer is on the source record.